Accuray Inc. (NASDAQ: ARAY) has named Jack Goldstein, P.hD., to serve as a member of its Board of Directors. Dr. Goldstein will assume the position immediately.
Dr. Goldstein is an independent consultant who most recently held the position of President and COO of CHron Corporate. He serves on the Board of Directors at OncoGenex Pharmaceuticals, Inc. and Orasure Technologies, Inc. He has successful run multi-billion dollar companies, created effective dales plans and developed start-up ventures.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer